What is the best management for tremor and anxiety in an older adult with dementia and Parkinson disease who is currently taking tramadol, sertraline, trazodone, acetaminophen, divalproex delayed‑release, lorazepam, morphine, hyoscyamine, bisacodyl, and acetaminophen suppositories?

Management of Tremor and Anxiety in This Patient

This patient's medication regimen requires urgent simplification and optimization, with lorazepam discontinuation as the highest priority, followed by optimization of levodopa therapy for tremor control.

Critical Medication Safety Issues

This patient is on a dangerously complex polypharmacy regimen with multiple concerning drug interactions and duplications that must be addressed immediately:

Immediate Concerns:

Lorazepam must be discontinued or tapered in this elderly patient with dementia and Parkinson's disease 1. Benzodiazepines:

• Increase fall risk substantially in elderly patients
• Worsen cognitive function in dementia
• Can paradoxically worsen agitation
• Have no evidence supporting use for anxiety in Parkinson's disease 2
• Are contraindicated in this population

Acetaminophen duplication - This patient is receiving THREE separate acetaminophen formulations (500mg TID, 650mg suppository PRN, 325mg PRN), creating serious risk of hepatotoxicity, especially with concurrent divalproex which can cause liver injury 3.

Serotonin syndrome risk - The combination of tramadol, sertraline, and trazodone creates significant risk for serotonin syndrome 4. Tramadol specifically interacts with sertraline per FDA labeling.

Tremor Management

First-Line Approach:

Levodopa is the most efficacious treatment for Parkinson's tremor and should be the primary approach 5, 6. This patient is NOT currently on levodopa, which represents a fundamental gap in their Parkinson's treatment.

Recommended tremor strategy:

• Initiate levodopa/carbidopa as the mainstay of treatment 5, 6
• Start with standard-release formulation during the day
• Consider extended-release at night if needed
• Add COMT inhibitor if necessary for optimization 5

Current Medications and Tremor:

• Divalproex - While used here for agitation, has no established role in PD tremor management
• Tramadol - May actually worsen tremor through serotonergic effects and should be reconsidered given safer alternatives for pain in elderly patients with dementia

Alternative Considerations if Levodopa Insufficient:

If tremor persists despite optimized levodopa 6:

• Propranolol may improve both resting and action tremor as adjunct therapy
• Anticholinergics are generally contraindicated in elderly patients with dementia due to cognitive worsening
• For medication-refractory tremor, deep brain stimulation (DBS) targeting STN or GPi is highly effective, though age and cognitive impairment may limit candidacy 7

Anxiety Management

Pharmacological Approach:

Sertraline should be continued as it is already prescribed at 100mg daily 8. Evidence supports SSRIs for anxiety in Parkinson's disease with modest effect sizes 2, 8. The FDA label confirms sertraline's use for anxiety disorders 4.

Key anxiety management principles:

• Optimize dopaminergic therapy first - Anxiety in PD is often related to "off" periods and improves with levodopa 2
• Once levodopa is initiated, anxiety may improve substantially without additional anxiolytics
• Discontinue lorazepam - Replace with optimization of sertraline and levodopa rather than another anxiolytic

Non-Pharmacological Strategies:

Per dementia guidelines 1, investigate and address:

• Pain (this patient has multiple pain medications suggesting undertreated pain)
• Environmental triggers for agitation/anxiety
• Caregiver communication patterns and expectations
• Medical causes: constipation (patient on bisacodyl PRN), infections, dehydration

Specific Recommendations

Immediate Actions:

1. Taper and discontinue lorazepam - No role in PD anxiety management, increases falls
2. Consolidate acetaminophen - Single scheduled dose with PRN option, monitor total daily dose <3g
3. Initiate levodopa/carbidopa - Primary treatment for PD tremor
4. Continue sertraline 100mg daily - Established for anxiety/depression in PD 8
5. Reassess tramadol - Consider safer alternatives given serotonin syndrome risk and interaction with sertraline 4

Divalproex Considerations:

The FDA label indicates divalproex requires careful monitoring in elderly patients with dose reductions and slower titration 3. In elderly patients:

• Greater sensitivity to somnolence
• Increased risk of thrombocytopenia at higher levels
• Should monitor for dehydration and decreased intake
• Consider whether agitation might improve with better tremor/anxiety control before continuing

Monitoring:

• Tremor response to levodopa within 2-4 weeks
• Anxiety levels after lorazepam discontinuation and levodopa optimization
• Cognitive function - avoid anticholinergics, minimize sedating medications
• Fall risk - especially during medication transitions
• Liver function - given divalproex and previous acetaminophen overload risk

Common Pitfalls to Avoid

• Do not add anticholinergics for tremor in elderly patients with dementia - will worsen cognition
• Do not continue benzodiazepines - no evidence of benefit, clear harm in this population 2
• Do not treat tremor without first optimizing dopaminergic therapy - levodopa is most effective 6
• Do not assume anxiety requires separate anxiolytic - often improves with better PD motor control 2
• Do not overlook medication simplification - polypharmacy itself worsens outcomes in elderly patients with dementia 5